Very good question.
I don't know.
I can see why EXEL mgmt can be trusted when they say BMY dumped it because (at least 3) their drugs are overlapping XL184. However, I don't trust George Scagnos anymore. He's getting $1.2 million a year and hasn't delivered anything.
XL184 seems like it has clear evidence of efficacy, but, then again, who knows with Scagnos running the company. Do you trust the evidence? Can you trust the evidence with him at the top?
Personally.....I think the Board of Directors should just sell this company in its entirely (but I don't know if thats even possible the way they have spread all their partnerships out so thin).
Market Data 
Markets 
AI
